Kids

Teen Pre-Workout and Weight-Loss Supplements: An Emergency Department Concern

Apr 26, 2026 · 7 min read

Adolescent emergency-department visits attributed to dietary supplement use rose sharply through the 2010s, with disproportionate harm concentrated in two product categories: weight-loss/fat-burner supplements (predominantly used by teenage girls) and stimulant-loaded pre-workout supplements (predominantly used by teenage boys). A 2017 study by Or et al. in the Journal of Adolescent Health found that adolescents using these categories were at meaningfully elevated risk of severe medical events. Consumer Reports, the FDA, and pediatric professional societies have issued repeated warnings; the supply side has continued to grow.

The Pre-Workout Stimulant Stack

Adult pre-workout products typically combine caffeine (150–400 mg/serving), beta-alanine, citrulline, and varying mixes of "stimulant" or "nootropic" compounds. Doses sized for 200-pound adult lifters can be problematic when consumed by 130-pound 16-year-olds, and label warnings against use under 18 are routinely ignored. Cases of cardiac arrhythmia, hypertension, vomiting, syncope, and rhabdomyolysis in adolescents using pre-workouts are reported in the pediatric emergency-medicine literature.

The Specific Bad Actors

Yohimbine in fat-burner products has been associated with ED visits for tachycardia, severe anxiety, and hypertensive crisis, particularly in adolescents with underlying anxiety disorders. Synephrine (bitter orange) is the most common ephedra replacement and has been implicated in cardiovascular events when stacked with caffeine. DMAA (1,3-dimethylamylamine) was banned by the FDA in 2013 after multiple deaths in U.S. military personnel; it nonetheless reappears in imported pre-workouts. DMHA (octodrine) followed a similar trajectory. Kratom, marketed for "energy" or "focus," carries opioid-receptor activity and addiction potential; pediatric exposures rose sharply through the early 2020s.

Weight-Loss Products and Eating Disorder Pipeline

The Harvard School of Public Health's Strategic Training Initiative for the Prevention of Eating Disorders (STRIPED) has documented that adolescents using diet pills, laxatives, or diuretics for weight control are at elevated risk of subsequent eating-disorder diagnosis. A 2019 prospective cohort published in American Journal of Public Health found that adolescent girls using weight-loss supplements were over five times more likely to receive an eating-disorder diagnosis within three years. The supplements function both as a precursor to and an enabler of disordered eating. Several U.S. states (New York, California, Massachusetts) have considered or passed legislation restricting sales of weight-loss supplements to minors.

Stimulant Laxative Products

"Detox tea" and "skinny tea" products marketed to adolescent girls typically contain senna, cascara, or other stimulant laxatives, often without prominent labeling. Repeated use causes electrolyte abnormalities, dehydration, and dependence. Hospitalization for hypokalemia in teenage girls following these products has been documented in case series.

Adulteration Is the Norm, Not the Exception

The FDA's Tainted Products Marketed as Dietary Supplements database lists thousands of products spiked with prescription pharmaceuticals: sibutramine (a withdrawn weight-loss drug), phenolphthalein (a withdrawn stimulant laxative), sildenafil and tadalafil (in "male enhancement" products that adolescents access), DNP (a discontinued industrial uncoupler causing fatal hyperthermia), and various designer steroids in muscle-building supplements. Adolescents purchasing these products through Amazon, eBay, or convenience-store outlets cannot reliably identify which are adulterated.

The Talk Pediatricians Should Be Having

The AAP recommends that pediatricians screen for supplement use in adolescent annual visits, particularly inquiring about pre-workouts, weight-loss aids, and "energy" products. The conversation should be non-judgmental but explicit about the lack of regulatory oversight, frequency of contamination, and the specific risks (cardiac, eating-disorder pipeline) associated with these categories.

What Parents Can Do

Audit the household supplement shelf with adolescents present and explicit about why specific products are being removed. Discuss what is being sold to them at gym counters, on TikTok, and at convenience stores. If your teen has been using a product and is symptomatic (palpitations, vomiting, dizziness, mood changes), preserve the bottle and seek medical evaluation. Most ED encounters resolve with supportive care; some, particularly DNP and certain DMAA exposures, do not.

Sources

  1. Or F, Kim Y, Simms J, Austin SB. "Taking Stock of Dietary Supplements' Harmful Effects on Children, Adolescents, and Young Adults." Journal of Adolescent Health, 2019;65(4):455–461. PMID 31303386. DOI 10.1016/j.jadohealth.2019.03.005.
  2. Geller AI, Shehab N, Weidle NJ, et al. "Emergency Department Visits for Adverse Events Related to Dietary Supplements." New England Journal of Medicine, 2015;373(16):1531–1540. PMID 26465986.
  3. Tucker J, Fischer T, Upjohn L, et al. "Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings." JAMA Network Open, 2018;1(6):e183337. PMID 30646238.
  4. Cohen PA, Travis JC, Keizers PHJ, et al. "Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)." Clinical Toxicology, 2018;56(6):421–426. PMID 29115866.
  5. Levinson JA, Sarda V, Sonneville K, et al. "Diet pill and laxative use for weight control predicts first-time receipt of an eating disorder diagnosis within 5 years in female adolescents and young adults." American Journal of Public Health, 2020;110(1):109–111. PMID 31725305.
  6. U.S. Food and Drug Administration. "Tainted Products Marketed as Dietary Supplements_CDER." Searchable database. Updated 2025.
  7. Cohen PA. "Hazards of hindsight — monitoring the safety of nutritional supplements." New England Journal of Medicine, 2014;370(14):1277–1280. PMID 24693886.
  8. Eichner AK, Coyles J, Fedoruk M, et al. "Essential features of third-party certification programs for dietary supplements: A consensus statement of the US Anti-Doping Agency Dietary Supplement Safety Working Group." Current Sports Medicine Reports, 2019;18(5):178–182. PMID 31082896.
  9. American Academy of Pediatrics, Council on Sports Medicine and Fitness. "Use of Performance-Enhancing Substances." Pediatrics, 2016;138(1):e20161300. PMID 27325634.

Reviewed against 9 peer-reviewed/regulatory sources.